<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id><journal-title>BMC Medical Genetics</journal-title><issn pub-type="epub">1471-2350</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2350-5-30</article-id><article-id pub-id-type="pmid">15613245</article-id><article-id pub-id-type="doi">10.1186/1471-2350-5-30</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><italic>Catechol-O-Methyltransferase (COMT) Val</italic><sup>108/158 </sup><italic>Met </italic>polymorphism does not modulate executive function in children with ADHD</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Taerk</surname><given-names>Evan</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>evantaerk@yahoo.ca</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Grizenko</surname><given-names>Natalie</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>grinat@douglas.mcgill.ca</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Amor</surname><given-names>Leila Ben</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>benlei@douglas.mcgill.ca</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Lageix</surname><given-names>Philippe</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>lagphi@douglas.mcgill.ca</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Mbekou</surname><given-names>Valentin</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>mbeval@douglas.mcgill.ca</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Deguzman</surname><given-names>Rosherie</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>degros@douglas.mcgill.ca</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Torkaman-Zehi</surname><given-names>Adam</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>torada@douglas.mcgill.ca</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Stepanian</surname><given-names>Marina Ter</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>termar@douglas.mcgill.ca</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Baron</surname><given-names>Chantal</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>barcha@douglas.mcgill.ca</email></contrib><contrib id="A10" contrib-type="author"><name><surname>Joober</surname><given-names>Ridha</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>joorid@douglas.mcgill.ca</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Psychiatry, McGill University and Douglas Hospital Research Centre, Montreal, Quebec, H4H 1R3, Canada</aff><aff id="I2"><label>2</label>Department Neurology and Neurosurgery, McGill University and Douglas Hospital Research Centre, Montreal, Quebec, H4H 1R3, Canada</aff><aff id="I3"><label>3</label>Department of Human Genetics, McGill University and Douglas Hospital Research Centre, Montreal, Quebec, H4H 1R3, Canada</aff><pub-date pub-type="collection"><year>2004</year></pub-date><pub-date pub-type="epub"><day>21</day><month>12</month><year>2004</year></pub-date><volume>5</volume><fpage>30</fpage><lpage>30</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/5/30"/><history><date date-type="received"><day>12</day><month>8</month><year>2004</year></date><date date-type="accepted"><day>21</day><month>12</month><year>2004</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2004 Taerk et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2004</copyright-year><copyright-holder>Taerk et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Taerk Evan evantaerk@yahoo.ca </dc:author><dc:title> Catechol-O-Methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD </dc:title><dc:date>2004</dc:date><dcterms:bibliographicCitation>BMC Medical Genetics 5(1): 30-. (2004)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2350(2004)5:1&#x0003c;30&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2350</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>An association has been observed between the <italic>catechol-O-methyltransferase </italic>(<italic>COMT</italic>) gene, the predominant means of catecholamine catabolism within the prefrontal cortex (PFC), and neuropsychological task performance in healthy and schizophrenic adults. Since several of the cognitive functions typically deficient in children with Attention Deficit Hyperactivity Disorder (ADHD) are mediated by prefrontal dopamine (DA) mechanisms, we investigated the relationship between a functional polymorphism of the <italic>COMT </italic>gene and neuropsychological task performance in these children.</p></sec><sec sec-type="methods"><title>Methods</title><p>The <italic>Val</italic><sup>108/158 </sup><italic>Met </italic>polymorphism of the <italic>COMT </italic>gene was genotyped in 118 children with ADHD (DSM-IV). The Wisconsin Card Sorting Test (WCST), Tower of London (TOL), and Self-Ordered Pointing Task (SOPT) were employed to evaluate executive functions. Neuropsychological task performance was compared across genotype groups using analysis of variance.</p></sec><sec><title>Results</title><p>ADHD children with the <italic>Val/Val</italic>, <italic>Val/Met </italic>and <italic>Met/Met </italic>genotypes were similar with regard to demographic and clinical characteristics. No genotype effects were observed for WCST standardized perseverative error scores [F<sub>2,97 </sub>= 0.67; p &#x0003e; 0.05], TOL standardized scores [F<sub>2,99 </sub>= 0.97; p &#x0003e; 0.05], and SOPT error scores [F<sub>2,108 </sub>= 0.62; p &#x0003e; 0.05].</p></sec><sec><title>Conclusions</title><p>Contrary to the observed association between WCST performance and the <italic>Val</italic><sup>108/158 </sup><italic>Met </italic>polymorphism of the <italic>COMT </italic>gene in both healthy and schizophrenic adults, this polymorphism does not appear to modulate executive functions in children with ADHD.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Attention Deficit Hyperactivity Disorder (ADHD) is a childhood psychiatric disorder characterized by symptoms of inattention, impulsivity and motor hyperactivity afflicting 6&#x02013;8% of school-aged children in North America [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Although ADHD is a disorder with complex and heterogeneous etiology, genetic factors appear to play a significant role in predisposing and perpetuating the development of the disorder as evidenced by twin [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>], family [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>], and adoption studies [<xref ref-type="bibr" rid="B8">8</xref>]. Association studies have implicated several susceptibility loci including a 40-base pair (bp) allele of the Variable Number of Tandem Repeats (VNTR) polymorphism of the <italic>SLC6A3 </italic>gene [<xref ref-type="bibr" rid="B9">9</xref>] and a 48-bp repeat polymorphism of the <italic>DRD4 </italic>gene [<xref ref-type="bibr" rid="B10">10</xref>]. Attempts to replicate these findings have met with modest success possibly owing to the clinical heterogeneity characteristic of the disorder [<xref ref-type="bibr" rid="B11">11</xref>]. One method that may act to augment the strength of these associations would be to identify endophenotypic intermediates conferring risk for the development of ADHD rather than attempting to identify direct linkages between genetic variations and the behavioural manifestation of the disorder.</p><p>Theories of dysregulated dopamine (DA) pathways in ADHD have been supported by the efficacy of dopamine agonists in reducing the core symptoms of the disorder [<xref ref-type="bibr" rid="B12">12</xref>]. The mesocortical DA pathway appears to be integral to prefrontal cortex (PFC)-mediated cognitive functioning, specifically working memory [<xref ref-type="bibr" rid="B13">13</xref>], through the enhancement of task-related neural activity via D1 receptor activation [<xref ref-type="bibr" rid="B14">14</xref>]. Both PET [<xref ref-type="bibr" rid="B15">15</xref>] and SPECT [<xref ref-type="bibr" rid="B16">16</xref>] imaging studies support a neuromodulatory role for DA in the PFC during tasks of executive function. In addition, administration of DA agonists to the rat PFC acts to enhance working memory in these animals [<xref ref-type="bibr" rid="B17">17</xref>]. Consistent with this line of thinking, children with ADHD show deficits in performance of tasks of executive function [summarized in a meta-analysis by Sergeant et al. (2002)] [<xref ref-type="bibr" rid="B18">18</xref>] and significant improvement of performance under methylphenidate [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. These findings have prompted the hypothesis that the overt symptoms of ADHD are the manifestation of an underlying deficiency in a range of PFC-mediated cognitive domains, including working memory, planning, and set shifting, collectively regarded as executive function [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>].</p><p>The hypothesized role of a dysfunctional mesocortical dopaminergic pathway in the development of symptoms of ADHD has encouraged the investigation of candidate genes involved in this pathway including <italic>SLC6A3 </italic>[<xref ref-type="bibr" rid="B9">9</xref>], <italic>DRD4 </italic>[<xref ref-type="bibr" rid="B10">10</xref>] and, more recently, the <italic>catechol-O-methyltransferase </italic>(<italic>COMT</italic>) gene [<xref ref-type="bibr" rid="B24">24</xref>]. The <italic>COMT</italic>, encoded by a gene located on chromosome 22q11, catalyzes the degradation of catecholamines, most importantly DA [<xref ref-type="bibr" rid="B25">25</xref>]. A functional polymorphism of this gene, involving a substitution of Valine (<italic>Val</italic>) for Methionine (<italic>Met</italic>) at codon 108/158 (<italic>Val</italic><sup>108/158 </sup><italic>Met</italic>), results in a 4-fold variation in enzyme activity, with individuals homozygous for either the <italic>Val </italic>or <italic>Met </italic>allele exhibiting either reduced or preserved levels of DA respectively [<xref ref-type="bibr" rid="B26">26</xref>]. Although the dopamine transporter (DAT) is the predominant means of DA termination in most dopaminergic neurons [<xref ref-type="bibr" rid="B27">27</xref>], considerable evidence exists to suggest that the DAT may play a reduced role within the PFC [<xref ref-type="bibr" rid="B28">28</xref>-<xref ref-type="bibr" rid="B32">32</xref>], where other clearance mechanisms may be implicated. Comparison of DA metabolite levels within discrete brain loci in both rats [<xref ref-type="bibr" rid="B33">33</xref>] and monkeys [<xref ref-type="bibr" rid="B34">34</xref>], as well as the measurement of DA levels in <italic>COMT </italic>knock-out mice [<xref ref-type="bibr" rid="B35">35</xref>], suggest an important functional role for <italic>COMT </italic>in the PFC. If <italic>COMT </italic>is indeed inextricably linked to DA metabolism within the PFC, it is reasonable to assume that variations in enzyme activity, as dictated by the <italic>Val</italic><sup>108/158 </sup><italic>Met </italic>polymorphism, may modulate the performance of tasks of executive functioning in healthy individuals, as well as individuals with reduced PFC basal dopamine levels. In support of this assumption, associations have been reported between the <italic>Val</italic><sup>108/158 </sup><italic>Met </italic>polymorphism and performance on the Wisconsin Card Sorting Test (WCST) in healthy adults [<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>]. In adults with Schizophrenia, a disorder characterized by dopaminergic hypofrontality [<xref ref-type="bibr" rid="B38">38</xref>], associations have also been observed between the <italic>COMT </italic>polymorphism and WCST performance [<xref ref-type="bibr" rid="B39">39</xref>-<xref ref-type="bibr" rid="B41">41</xref>]. Although one study reported an association between the <italic>COMT </italic>polymorphism and ADHD using a haplotype relative risk design [<xref ref-type="bibr" rid="B24">24</xref>], this study failed to investigate any indices of executive function and several other studies failed to replicate this finding [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B42">42</xref>-<xref ref-type="bibr" rid="B44">44</xref>].</p><p>Given the putative role of <italic>COMT </italic>in DA metabolism within the PFC [<xref ref-type="bibr" rid="B33">33</xref>-<xref ref-type="bibr" rid="B35">35</xref>], we hypothesized that the <italic>Val</italic><sup>108/158 </sup><italic>Met </italic>polymorphism of the <italic>COMT </italic>gene will be associated with alterations in performance on tasks of executive function, a behavioural index of PFC integrity and function [<xref ref-type="bibr" rid="B45">45</xref>]. Since dysfunctional DA neurotransmission [<xref ref-type="bibr" rid="B46">46</xref>] and deficient neuropsychological task performance [<xref ref-type="bibr" rid="B18">18</xref>] are both characteristic of children with ADHD, we further hypothesized that this association would be evident within this particular clinical population. Specifically, ADHD children expressing the high enzymatic activity <italic>Val </italic>allele (H), resulting in reduced PFC DA neurotransmission [<xref ref-type="bibr" rid="B26">26</xref>], will show more pronounced deficits in neuropsychological task performance than their low enzymatic activity <italic>Met </italic>allele (L) counterparts. In order to test this hypothesis, we used three measures of executive function: the WCST [<xref ref-type="bibr" rid="B47">47</xref>], a measure of set-shifting ability capable of differentiating between ADHD children and controls [<xref ref-type="bibr" rid="B18">18</xref>] and associated with the COMT polymorphism in normal [<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>] and schizophrenic adults [<xref ref-type="bibr" rid="B39">39</xref>-<xref ref-type="bibr" rid="B41">41</xref>]; the Tower of London (TOL) [<xref ref-type="bibr" rid="B48">48</xref>], a measure of planning ability, which consistently differentiates ADHD children from controls [<xref ref-type="bibr" rid="B18">18</xref>], and the Self-Ordered Pointing Task (SOPT) [<xref ref-type="bibr" rid="B49">49</xref>], a measure of working memory also capable of differentiating between ADHD children and controls [<xref ref-type="bibr" rid="B18">18</xref>].</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>118 children were recruited from the Disruptive Behaviour Disorders Program and the children outpatient clinic at the Douglas Hospital. They were referred to these specialized care facilities by school principals, community social workers, and paediatricians.</p><p>Inclusion criteria required children to be between the ages of 6 and 12 years of age, meeting DSM-IV diagnosis criteria for ADHD [<xref ref-type="bibr" rid="B50">50</xref>]. Diagnosis of ADHD was based on a structured clinical interview of parents using the DISC-IV (parental report) [<xref ref-type="bibr" rid="B51">51</xref>], school reports, teacher interviews, and clinical observation of the child. In the majority of cases, mothers were the primary informants for the collection of clinical information. Written reports from the child's school were also available in the majority of cases. Parents completed the Child Behavioural Checklist (CBCL) [<xref ref-type="bibr" rid="B52">52</xref>], a scale that assesses a variety of behavioural domains, and the Conners' Global Index for parents (CGI-P) [<xref ref-type="bibr" rid="B53">53</xref>]. Teachers also completed the Conners' Global Index (CGI-T) [<xref ref-type="bibr" rid="B54">54</xref>]. Assessments were made while children were free of medication. Exclusion criteria included a history of mental retardation, with an IQ less than or equal to 70 as measured by the WISC-III [<xref ref-type="bibr" rid="B55">55</xref>], and history of Tourette Syndrome, pervasive developmental disorder, psychosis or any medical condition or impairment that may interfere with the child's ability to complete the study.</p></sec><sec><title>Neurocognitive assessment</title><p>A comprehensive neuropsychological test battery assessing different aspects of the central executive functions was administered to all children by trained research personnel. All children were assessed subsequent to a one-week medication "wash-out" period. Children were permitted to take breaks upon request and, in some cases, testing was carried out over two sessions. On average, the testing procedure lasted 1.5 hours. The research protocol was approved by the Research Ethics Board of the Douglas Hospital. Parents were explained the study and provided written consent. Children were also explained the study and gave their assent to participate as well.</p><p>Tests were selected according to their ability to tap into various performance domains of executive function. We restricted the number of tests in each domain in order to balance comprehensiveness with the co-operation of patients. Abstraction and concept formation were evaluated by means of the WCST (perseverative errors) [<xref ref-type="bibr" rid="B47">47</xref>]. In this task, children are required to sort cards according to three different criteria (colour, number, or shape of signs presented on cards). Feedback on whether the child achieved a correct or incorrect match is given after each trial. The matching criterion changes after ten consecutive correct matches and the child has to identify the new matching criterion using the feedback (correct/incorrect) provided to them. Evidence of the reliability and validity of the WCST with various normal and clinical populations has been reported in several studies [<xref ref-type="bibr" rid="B18">18</xref>]. Planning capacity was evaluated using the TOL [<xref ref-type="bibr" rid="B48">48</xref>]. This test is used to assess planning and problem solving aspects of executive functioning. The validity and reliability of the TOL has been reported in numerous studies [<xref ref-type="bibr" rid="B18">18</xref>]. Standardized administration and scoring procedures as well as normative data have been developed for paediatric populations [<xref ref-type="bibr" rid="B56">56</xref>]. Visual Working Memory was evaluated using the abstract version of the SOPT [<xref ref-type="bibr" rid="B49">49</xref>]. In this task, series of matrices of 6, 8, 10, and 12 images are presented to the child. The child is asked to select, by pointing, one different image on each page. Errors occur when the child points to images previously selected on the preceding pages. Each set is presented to the child three times. Successful performance on this task involves working memory as well as planning and monitoring skills. Shue &#x00026; Douglas (1992) have reported significant differences in performance between ADHD children and normal controls on the SOPT [<xref ref-type="bibr" rid="B57">57</xref>].</p></sec><sec><title>Molecular genetics</title><p>The <italic>Val</italic><sup>108/158 </sup><italic>Met </italic>polymorphism of the <italic>COMT </italic>gene was genotyped using a PCR based method as previously described [<xref ref-type="bibr" rid="B26">26</xref>]. The PCR was performed in a 25 &#x003bc;l total reaction volume containing 1X PCR buffer, 200 uM dNTPs, 200 ng of primers (5'-GCGATGGTGGCACTCCAAGC; 5'-TTGGAGAGGCTGAGGCTGAC), 1 unit of Taq DNA polymerase, and 100 ng of genomic DNA. PCR products were electrophoresed on agarose-TAE gel along with 1 kb ad 100 bp DNA ladders, visualized under UV-light and coded according to the length of the PCR product. Genotypes were called by two independent and experienced technicians who were blind to all clinical data. No disconcordance in any of the readings was noted. Children were stratified according to genotype only after all neuropsychological task data was collected.</p></sec><sec><title>Statistical analyses</title><p>The <italic>Val</italic><sup>108/158 </sup><italic>Met </italic>polymorphism consists of both the low-activity <italic>Met </italic>(L) and high-activity <italic>Val </italic>(H) alleles. Subjects were stratified into three groups: two homozygous genotype groups (LL, HH) and one heterozygous genotype group (HL).</p><p>A one-way analysis of variance (ANOVA) where genotype (LL, HL, HH) was the independent variable and neuropsychological task performance (standardized WCST perseverative error score, standardized TOL total item score) was the dependent variable was performed. For the SOPT, no normalized scores are available and testing procedures involve several levels of difficulty (4). We therefore used a two-way, repeated measure, mixed design analysis of covariance (ANCOVA), where genotype and level of task difficulty were the between and within subjects independent variables, respectively, neuropsychological task performance (SOPT raw error score) was the dependent variable, and age was the covariate. As the TOL also involves multiple levels of task difficulty (12), we repeated the analysis for this test using the same statistical approach as that applied to the SOPT. A one-way ANCOVA, where genotype was the independent variable and age was the covariate, was performed on all other non-standardized measures of neuropsychological task performance (WCST number of categories completed, WCST number of trials to first category, TOL number of problems solved).</p><p>An investigation of linkage and within-family association between quantitative phenotypes (standardized WCST perseverative error score, standardized TOL error score, and SOPT error score) was conducted utilizing the Quantitative Trait Disequilibrium Test (QTDT) statistical software package [<xref ref-type="bibr" rid="B58">58</xref>].</p></sec></sec><sec><title>Results</title><p>Table <xref ref-type="table" rid="T1">1</xref> shows clinical and demographic information for the children stratified according to genotype [n = 23 for LL (19.5%), n = 66 for HL (56.0%) and n = 29 for HH (24.5%)]. The three groups were similar with regard to age, average household income, severity of behavioural problems as assessed by the CBCL, and mean number of inattention items, mean number of hyperactivity items and distribution of ADHD subtypes according to the DISC-IV. No significant differences existed between the groups in IQ as measured by the WISC-III. Our sample was characterized by a high prevalence of comorbid disorders, particularly oppositional defiant disorder and conduct disorder. The frequency of these disorders was equally distributed between the genotype groups. The proportion of subjects who had never received medication for ADHD within each genotype group was also remarkably similar. Although a significant effect of gender was observed between genotype groups (&#x003c7;<sup>2 </sup>= 7.39; df = 2, p = 0.02), this result was treated as a type I error (false positive) due to the absence of female subjects with the HH genotype and given the relative lack of female representation across all genotype groups. However, given the previously observed association between gender and several polymorphisms at the <italic>COMT </italic>loci [<xref ref-type="bibr" rid="B59">59</xref>], increasing the sample size to achieve a more comparable gender representation and distribution would be a valuable revision to the present design.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Demographic and clinical characteristics of children with ADHD separated according to COMT genotype</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left">LL (23)</td><td align="left">HL (66)</td><td align="left">HH (29)</td><td align="left">p-value</td></tr></thead><tbody><tr><td align="left">Gender (M/F)</td><td align="left">20/3</td><td align="left">52/14</td><td align="left">29/0</td><td align="left">&#x003c7;<sup>2 </sup>= 7.39, df = 2 p = 0.02</td></tr><tr><td align="left">Age</td><td align="left">9.2 (2.0)</td><td align="left">9.0 (1.8)</td><td align="left">9.3 (1.7)</td><td align="left">F<sub>2,115 </sub>= 0.21, p = 0.81</td></tr><tr><td align="left">IQ</td><td align="left">97.2 (13.7)</td><td align="left">97.5 (13.5)</td><td align="left">95.6 (13.8)</td><td align="left">F<sub>2,98 </sub>= 0.17, p = 0.84</td></tr><tr><td align="left">CBCL (total score)</td><td align="left">68.0 (9.8)</td><td align="left">70.9 (10.4)</td><td align="left">68.9 (8.9)</td><td align="left">F<sub>2,112 </sub>= 0.87, p = 0.42</td></tr><tr><td align="left">Income (% less than 20 K)</td><td align="left">32 %</td><td align="left">42 %</td><td align="left">48 %</td><td align="left">&#x003c7;<sup>2 </sup>= 1.39, df = 2 p = 0.50</td></tr><tr><td align="left">DISC-IV Inattention Items</td><td align="left">7.3 (1.5)</td><td align="left">6.9 (2.2)</td><td align="left">7.2 (2.3)</td><td align="left">F<sub>2,113 </sub>= 0.46, p = 0.63</td></tr><tr><td align="left">DISC-IV Hyperactivity Items</td><td align="left">5.9 (2.4)</td><td align="left">6.4 (2.3)</td><td align="left">6.4 (2.7)</td><td align="left">F<sub>2,113 </sub>= 0.33, p = 0.72</td></tr><tr><td align="left">DISC-IV ADHD Subtype (I/H/C)</td><td align="left">10/3/10</td><td align="left">14/13/39</td><td align="left">7/3/19</td><td align="left">&#x003c7;<sup>2 </sup>= 5.68, df = 2 p = 0.22</td></tr><tr><td align="left">Comorbid ODD</td><td align="left">13/23</td><td align="left">50/66</td><td align="left">20/27</td><td align="left">&#x003c7;<sup>2 </sup>= 3.21, df = 2 p = 0.20</td></tr><tr><td align="left">Comorbid CD</td><td align="left">5/23</td><td align="left">27/64</td><td align="left">8/27</td><td align="left">&#x003c7;<sup>2 </sup>= 3.57, df = 2 p = 0.17</td></tr><tr><td align="left">Never Medicated</td><td align="left">11/22</td><td align="left">38/62</td><td align="left">18/28</td><td align="left">&#x003c7;<sup>2 </sup>= 1.17, df = 2 p = 0.56</td></tr></tbody></table><table-wrap-foot><p>CBCL = Child Behavioral Checklist. DISC-IV = Diagnostic Interview Schedule for Children fourth edition. ODD = Opposition Defiant Disorder, CD = Conduct Disorder. ADHD Subtypes: I = Inattentive, H = Hyperactive, C = Combined. Values are mean (SD).</p></table-wrap-foot></table-wrap><p>The genotype distribution conformed to a Hardy-Weinberg equilibrium (&#x003c7;<sup>2 </sup>= 0.42; df = 2, p = 0.81). 156 parents participated in the study and gave blood samples. Among these parents, 76 were heterozygous (M = 43 and F = 33) and transmitted the <italic>Val </italic>allele to their affected children in 28 occurrences, whereas this same allele was not transmitted in 29 occurrences [&#x003c7;<sup>2 </sup>= 0.02; df = 1, p &#x0003e; 0.05 (transmission disequilibrium)]. Conversely, parents transmitted the <italic>Met </italic>allele to their affected children in 29 occurrences, whereas this same allele was not transmitted in 28 occurrences [&#x003c7;<sup>2 </sup>= 0.02; df = 1, p &#x0003e; 0.05 (transmission disequilibrium)]. In addition, results from the QTDT revealed no evidence of linkage or within-family association between the three quantitative phenotypes and the <italic>COMT </italic>gene.</p><p>A one-way ANOVA performed on these data revealed no significant difference between the LL, HL, and HH genotypes according to WCST standardized perseverative error scores [F<sub>2,97 </sub>= 0.66, p &#x0003e; 0.05](Table <xref ref-type="table" rid="T2">2</xref>) and TOL standardized total item scores [F<sub>2,99 </sub>= 0.97, p &#x0003e; 0.05](Table <xref ref-type="table" rid="T2">2</xref>). A repeated-measure, mixed design ANCOVA performed on these data revealed no effect of genotype on SOPT raw error scores [F<sub>2,108 </sub>= 0.62, p &#x0003e; 0.05] (Table <xref ref-type="table" rid="T2">2</xref>), TOL raw item scores [F<sub>2,107 </sub>= 0.35, p &#x0003e; 0.05], and TOL time to complete each trial [F<sub>2,108 </sub>= 0.04, p &#x0003e; 0.05]. No genotype by task interaction was observed for SOPT raw error scores [F<sub>6,327 </sub>= 0.39, p &#x0003e; 0.05], TOL raw item scores [F<sub>11,1199 </sub>= 1.63, p &#x0003e; 0.05], and TOL time to complete each trial [F<sub>11,1210 </sub>= 1.65, p &#x0003e; 0.05]. A one-way ANCOVA performed on these data revealed no effect of genotype on WCST number of categories completed [F<sub>2,96 </sub>= 1.94, p &#x0003e; 0.05], WCST number of trials to first category [F<sub>2,96 </sub>= 1.04, p &#x0003e; 0.05] and TOL number of problems solved [F<sub>2,112 </sub>= 1.04, p &#x0003e; 0.05]. No genotype effects were observed when the HL and HH genotype groups were combined into one category and contrasted with the LL genotype (recessive model) on WCST standardized perseverative error scores [F<sub>1,98 </sub>= 1.11, p &#x0003e; 0.05], WCST number of categories completed [F<sub>1,97 </sub>= 0.01, p &#x0003e; 0.05], WCST number of trials to first category [F<sub>1,97 </sub>= 0.36, p &#x0003e; 0.05], TOL standardized total item scores [F<sub>1,100 </sub>= 0.42, p &#x0003e; 0.05], TOL raw item scores [F<sub>1,108 </sub>= 0.22, p &#x0003e; 0.05], TOL time to complete each trial [F<sub>1,109 </sub>= 0.07, p &#x0003e; 0.05], TOL number of problems solved [F<sub>1,113</sub>= 1.33, p &#x0003e; 0.05] and SOPT raw error scores [F<sub>1,109 </sub>= 0.85, p &#x0003e; 0.05].</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Neuropsychological task performance in children with ADHD</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left">LL (23)</td><td align="left">HL (66)</td><td align="left">HH (29)</td><td align="left">ES</td><td align="left">p-value</td></tr></thead><tbody><tr><td align="left">WCST</td><td align="left">96.3 (15.1)</td><td align="left">99.1 (11.8)</td><td align="left">100.6 (12.2)</td><td align="left">0.31</td><td align="left">F<sub>2,97 </sub>= 0.67, p = 0.52</td></tr><tr><td align="left">TOL</td><td align="left">103.3 (16.5)</td><td align="left">99.5 (15.1)</td><td align="left">103.8 (12.6)</td><td align="left">0.03</td><td align="left">F<sub>2,99 </sub>= 0.97, p = 0.38</td></tr><tr><td align="left">SOPT</td><td align="left">13.5 (6.9)</td><td align="left">15.1 (8.8)</td><td align="left">15.8 (8.2)</td><td align="left">0.31</td><td align="left">F<sub>2,108 </sub>= 0.62, p = 0.54</td></tr></tbody></table><table-wrap-foot><p>WCST = Wisconsin Card Sorting Test standardized perseverative error score (LL: n = 21, HL: n = 56, HH: n = 23). TOL = Tower of London standardized score (LL: n = 20, HL: n = 55, HH: n = 27). SOPT = Self Ordered Pointing Task error score (LL: n = 23, HL: n = 63, HH: n = 26). ES = Effect size for LL vs. HH. Values are mean (SD).</p></table-wrap-foot></table-wrap></sec><sec><title>Discussion</title><p>Previous studies have identified an association between the <italic>COMT </italic>polymorphism and a variety of indices reflecting executive control both in healthy [<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>] and schizophrenic adults [<xref ref-type="bibr" rid="B39">39</xref>-<xref ref-type="bibr" rid="B41">41</xref>]. The <italic>COMT </italic>appears to be important to the regulation of dopamine metabolism within the PFC [<xref ref-type="bibr" rid="B33">33</xref>-<xref ref-type="bibr" rid="B35">35</xref>]. Since the PFC and dopamine pathways have been hypothesized to play an important role in the pathogenesis of ADHD [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B61">61</xref>]), we conducted this study in an attempt to test whether the <italic>COMT Val</italic><sup>108/158</sup><italic>Met </italic>polymorphism, which is known to be associated with a significant change in the catabolic capacity of this enzyme, modulates the risk for ADHD or various indices of executive control. Contrary to our expectations and findings in both healthy [<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>] and schizophrenic adults [<xref ref-type="bibr" rid="B39">39</xref>-<xref ref-type="bibr" rid="B41">41</xref>], an association between the <italic>Val</italic><sup>108/158 </sup><italic>Met </italic>functional polymorphism of the <italic>COMT </italic>gene and neuropsychological task performance reflecting executive control was not observed in children with ADHD. This result is consistent with the findings of a recent case-control study conducted by Mills et al. (2004), which, to our knowledge, is the only other study to investigate the relationship between the <italic>COMT Val</italic><sup>108/158</sup><italic>Met </italic>polymorphism and neuropsychological task performance in children with ADHD [<xref ref-type="bibr" rid="B62">62</xref>]. However, this study did not include the WCST, the measure responsible for producing the most consistent results in the previous literature. In addition, we did not identify a biased transmission of either of the two alleles from parents to affected offspring.</p><p>The absence of an association between the <italic>COMT Val</italic><sup>108/158</sup><italic>Met </italic>polymorphism and behavioral indices of executive function in children with ADHD may be explained by the young age of the population of patients included in the present study. Indeed it is possible that, due to age-related changes in the functional importance of the <italic>COMT </italic>within the prefrontal cortex, this association is observable only in adults. This possibility is supported by data in both rats [<xref ref-type="bibr" rid="B63">63</xref>-<xref ref-type="bibr" rid="B65">65</xref>] and humans [<xref ref-type="bibr" rid="B66">66</xref>,<xref ref-type="bibr" rid="B67">67</xref>] suggesting that monoamine content and metabolism decrease with age. This age-related decrease may render functions dependent on monoamine content more prone to be dysfunctional at an older age. In addition, evidence from rat studies has indicated a positive correlation between aging and <italic>COMT </italic>activity [<xref ref-type="bibr" rid="B68">68</xref>-<xref ref-type="bibr" rid="B70">70</xref>]. This observation may suggest that the implication of the <italic>COMT </italic>in the catabolism of dopamine is developmentally regulated, with children relying less on this catabolic pathway than adults. Conversely, it has been reported that DAT density is inversely correlated with age [<xref ref-type="bibr" rid="B71">71</xref>]. Taken together, the presence of an inverse and direct correlation between age and DAT density on the one hand and <italic>COMT </italic>activity on the other hand, may suggest that dopamine metabolism relies more on the DAT than on <italic>COMT </italic>activity in children compared to adults. This hypothesis is compatible with the fact that several studies have identified an association between the DAT [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B72">72</xref>-<xref ref-type="bibr" rid="B74">74</xref>], but not the <italic>COMT</italic>, gene and ADHD.</p><p>It is also possible that the negative result observed in the present study is due to a type II error (false negative) secondary to the lack of power of our sample to detect an association. However, using results from the WCST, the variable for which relevant genetic data already exists, we conducted a power analysis and determined that our sample size has sufficient power (80% at &#x003b1; = .05) to detect a mean difference of 11.2 on this measure. Furthermore, it is possible that some of the tests used in our assessment are mediated by the PFC but insensitive to PFC DA levels [<xref ref-type="bibr" rid="B75">75</xref>].</p><p>An additional limitation of the present study is that some genotype groups included few subjects. Increasing the sample size to achieve larger genotype groups would be necessary to reach firmer conclusions. This is particularly true for female subjects who were significantly underrepresented in the study (as is common to most clinical studies of ADHD). In order to generalize these negative results to females, a more comparable gender representation is required, particularly in view of some previous research indicating that the allelic distribution of the COMT may be gender dependent [<xref ref-type="bibr" rid="B59">59</xref>].</p></sec><sec><title>Conclusions</title><p>This study does not support the involvement of the <italic>Val</italic><sup>108/158 </sup><italic>Met </italic>polymorphism of the <italic>COMT </italic>gene in increasing the risk for ADHD or in modulating several indices of executive functions in children with ADHD. This result is contrary to previous findings in both healthy and schizophrenic adults and may be related to developmental specificities.</p></sec><sec><title>Competing interests</title><p>The author(s) declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>ET performed the data analysis and drafted the manuscript. NG was involved in the conception of the study and provided clinical support. LBA provided clinical support and aided in data collection. PL provided clinical support. VM aided in neuropsychological testing and data collection. RD and ATZ performed the genotyping for the study and aided in data management. MTS coordinated the clinical aspects of the study and was involved in data management. CB provided clinical support. RJ was responsible for the conception of the study, drafting of the manuscript, and supervision of the research project.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/5/30/prepub"/></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This work was supported in part by grants from the Fonds de la Recherche en Sant&#x000e9; du Qu&#x000e9;bec, R&#x000e9;seau de Sant&#x000e9; Mentale du Qu&#x000e9;bec, and the Canadian Institutes of Health Research to RJ and ET. We thank Johanne Bellingham, Anna Polotskaia and Nicole Pawliuk for technical assistance.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szatmari</surname><given-names>P</given-names></name><name><surname>Offord</surname><given-names>DR</given-names></name><name><surname>Boyle</surname><given-names>MH</given-names></name></person-group><article-title>Ontario Child Health Study: prevalence of attention deficit disorder with hyperactivity</article-title><source>J Child Psychol Psychiatry</source><year>1989</year><volume>30</volume><fpage>219</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">2708462</pub-id></citation></ref><ref id="B2"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Barkley</surname><given-names>RA</given-names></name></person-group><source>Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment</source><year>1990</year><publisher-name>New York: Guilford</publisher-name></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barr</surname><given-names>CL</given-names></name><name><surname>Wigg</surname><given-names>K</given-names></name><name><surname>Malone</surname><given-names>M</given-names></name><name><surname>Schachar</surname><given-names>R</given-names></name><name><surname>Tannock</surname><given-names>R</given-names></name><name><surname>Roberts</surname><given-names>W</given-names></name><name><surname>Kennedy</surname><given-names>JL</given-names></name></person-group><article-title>Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder</article-title><source>Am J Med Genet</source><year>1999</year><volume>88</volume><fpage>710</fpage><lpage>713</lpage><pub-id pub-id-type="pmid">10581494</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19991215)88:6&#x0003c;710::AID-AJMG23&#x0003e;3.0.CO;2-Q</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>F</given-names></name><name><surname>Hay</surname><given-names>DA</given-names></name><name><surname>McStephen</surname><given-names>M</given-names></name><name><surname>Wood</surname><given-names>C</given-names></name><name><surname>Waldman</surname><given-names>I</given-names></name></person-group><article-title>Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study</article-title><source>J Am Acad Child Adolesc Psychiatry</source><year>1997</year><volume>36</volume><fpage>737</fpage><lpage>744</lpage><pub-id pub-id-type="pmid">9183127</pub-id><pub-id pub-id-type="doi">10.1097/00004583-199706000-00009</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biederman</surname><given-names>J</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Keenan</surname><given-names>K</given-names></name><name><surname>Benjamin</surname><given-names>J</given-names></name><name><surname>Krifcher</surname><given-names>B</given-names></name><name><surname>Moore</surname><given-names>C</given-names></name><name><surname>Sprich-Buckminster</surname><given-names>S</given-names></name><name><surname>Ugaglia</surname><given-names>K</given-names></name><name><surname>Jellinek</surname><given-names>MS</given-names></name><name><surname>Steingard</surname><given-names>R</given-names></name></person-group><article-title>Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples</article-title><source>Arch Gen Psychiatry</source><year>1992</year><volume>49</volume><fpage>728</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">1514878</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Biederman</surname><given-names>J</given-names></name><name><surname>Milberger</surname><given-names>S</given-names></name></person-group><article-title>An exploratory study of ADHD among second-degree relatives of ADHD children</article-title><source>Biol Psychiatry</source><year>1994</year><volume>35</volume><fpage>398</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">8018786</pub-id><pub-id pub-id-type="doi">10.1016/0006-3223(94)90006-X</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hechtman</surname><given-names>L</given-names></name></person-group><article-title>Families of children with attention deficit hyperactivity disorder: a review</article-title><source>Can J Psychiatry</source><year>1996</year><volume>41</volume><fpage>350</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">8862854</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cadoret</surname><given-names>RJ</given-names></name><name><surname>Stewart</surname><given-names>MA</given-names></name></person-group><article-title>An adoption study of attention deficit/hyperactivity/aggression and their relationship to adult antisocial personality</article-title><source>Compr Psychiatry</source><year>1991</year><volume>32</volume><fpage>73</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">2001624</pub-id><pub-id pub-id-type="doi">10.1016/0010-440X(91)90072-K</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>EH</given-names><suffix>Jr</suffix></name><name><surname>Stein</surname><given-names>MA</given-names></name><name><surname>Krasowski</surname><given-names>MD</given-names></name><name><surname>Cox</surname><given-names>NJ</given-names></name><name><surname>Olkon</surname><given-names>DM</given-names></name><name><surname>Kieffer</surname><given-names>JE</given-names></name><name><surname>Leventhal</surname><given-names>BL</given-names></name></person-group><article-title>Association of attention-deficit disorder and the dopamine transporter gene</article-title><source>Am J Hum Genet</source><year>1995</year><volume>56</volume><fpage>993</fpage><lpage>998</lpage><pub-id pub-id-type="pmid">7717410</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>LaHoste</surname><given-names>GJ</given-names></name><name><surname>Swanson</surname><given-names>JM</given-names></name><name><surname>Wigal</surname><given-names>SB</given-names></name><name><surname>Glabe</surname><given-names>C</given-names></name><name><surname>Wigal</surname><given-names>T</given-names></name><name><surname>King</surname><given-names>N</given-names></name><name><surname>Kennedy</surname><given-names>JL</given-names></name></person-group><article-title>Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder</article-title><source>Mol Psychiatry</source><year>1996</year><volume>1</volume><fpage>121</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">9118321</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Biederman</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>WJ</given-names></name><name><surname>Milberger</surname><given-names>S</given-names></name><name><surname>Warburton</surname><given-names>R</given-names></name><name><surname>Tsuang</surname><given-names>MT</given-names></name></person-group><article-title>Genetic heterogeneity in attention-deficit hyperactivity disorder (ADHD): gender, psychiatric comorbidity, and maternal ADHD</article-title><source>J Abnorm Psychol</source><year>1995</year><volume>104</volume><fpage>334</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">7790635</pub-id><pub-id pub-id-type="doi">10.1037//0021-843X.104.2.334</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>LE</given-names></name><name><surname>Abikoff</surname><given-names>HB</given-names></name><name><surname>Cantwell</surname><given-names>DP</given-names></name><name><surname>Conners</surname><given-names>CK</given-names></name><name><surname>Elliott</surname><given-names>G</given-names></name><name><surname>Greenhill</surname><given-names>LL</given-names></name><name><surname>Hechtman</surname><given-names>L</given-names></name><name><surname>Hinshaw</surname><given-names>SP</given-names></name><name><surname>Hoza</surname><given-names>B</given-names></name><name><surname>Jensen</surname><given-names>PS</given-names></name><name><surname>Kraemer</surname><given-names>HC</given-names></name><name><surname>March</surname><given-names>JS</given-names></name><name><surname>Newcorn</surname><given-names>JH</given-names></name><name><surname>Pelham</surname><given-names>WE</given-names></name><name><surname>Richters</surname><given-names>JE</given-names></name><name><surname>Schiller</surname><given-names>E</given-names></name><name><surname>Severe</surname><given-names>JB</given-names></name><name><surname>Swanson</surname><given-names>JM</given-names></name><name><surname>Vereen</surname><given-names>D</given-names></name><name><surname>Wells</surname><given-names>KC</given-names></name></person-group><article-title>National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices</article-title><source>Arch Gen Psychiatry</source><year>1997</year><volume>54</volume><fpage>865</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">9294378</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group><article-title>The cortical dopamine system: role in memory and cognition</article-title><source>Adv Pharmacol</source><year>1998</year><volume>42</volume><fpage>707</fpage><lpage>711</lpage><pub-id pub-id-type="pmid">9327997</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>GV</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group><article-title>Modulation of memory fields by dopamine D1 receptors in prefrontal cortex</article-title><source>Nature</source><year>1995</year><volume>376</volume><fpage>572</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">7637804</pub-id><pub-id pub-id-type="doi">10.1038/376572a0</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattay</surname><given-names>VS</given-names></name><name><surname>Berman</surname><given-names>KF</given-names></name><name><surname>Ostrem</surname><given-names>JL</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name><name><surname>Van Horn</surname><given-names>JD</given-names></name><name><surname>Bigelow</surname><given-names>LB</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name></person-group><article-title>Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study</article-title><source>J Neurosci</source><year>1996</year><volume>16</volume><fpage>4816</fpage><lpage>4822</lpage><pub-id pub-id-type="pmid">8764668</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Daniel</surname><given-names>DG</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name><name><surname>Jones</surname><given-names>DW</given-names></name><name><surname>Zigun</surname><given-names>JR</given-names></name><name><surname>Coppola</surname><given-names>R</given-names></name><name><surname>Handel</surname><given-names>S</given-names></name><name><surname>Bigelow</surname><given-names>LB</given-names></name><name><surname>Goldberg</surname><given-names>TE</given-names></name><name><surname>Berman</surname><given-names>KF</given-names></name><name><surname>Kleinman</surname><given-names>JE</given-names></name></person-group><article-title>The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia</article-title><source>J Neurosci</source><year>1991</year><volume>11</volume><fpage>1907</fpage><lpage>1917</lpage><pub-id pub-id-type="pmid">2066768</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Floresco</surname><given-names>SB</given-names></name><name><surname>Phillips</surname><given-names>AG</given-names></name></person-group><article-title>Delay-dependent modulation of memory retrieval by infusion of a dopamine D1 agonist into the rat medial prefrontal cortex</article-title><source>Behav Neurosci</source><year>2001</year><volume>115</volume><fpage>934</fpage><lpage>939</lpage><pub-id pub-id-type="pmid">11508732</pub-id><pub-id pub-id-type="doi">10.1037//0735-7044.115.4.934</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sergeant</surname><given-names>JA</given-names></name><name><surname>Geurts</surname><given-names>H</given-names></name><name><surname>Oosterlaan</surname><given-names>J</given-names></name></person-group><article-title>How specific is a deficit of executive functioning for attention-deficit/hyperactivity disorder?</article-title><source>Behav Brain Res</source><year>2002</year><volume>130</volume><fpage>3</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">11864714</pub-id><pub-id pub-id-type="doi">10.1016/S0166-4328(01)00430-2</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>VI</given-names></name><name><surname>Barr</surname><given-names>RG</given-names></name><name><surname>O'Neill</surname><given-names>ME</given-names></name><name><surname>Britton</surname><given-names>BG</given-names></name></person-group><article-title>Short term effects of methylphenidate on the cognitive, learning and academic performance of children with attention deficit disorder in the laboratory and the classroom</article-title><source>J Child Psychol Psychiatry</source><year>1986</year><volume>27</volume><fpage>191</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">3514644</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>T</given-names></name><name><surname>Douglas</surname><given-names>VI</given-names></name><name><surname>Barr</surname><given-names>RG</given-names></name></person-group><article-title>Effects of methylphenidate on complex cognitive processing in attention-deficit hyperactivity disorder</article-title><source>J Abnorm Psychol</source><year>1999</year><volume>108</volume><fpage>90</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">10066996</pub-id><pub-id pub-id-type="doi">10.1037//0021-843X.108.1.90</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barkley</surname><given-names>RA</given-names></name></person-group><article-title>Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD</article-title><source>Psychol Bull</source><year>1997</year><volume>121</volume><fpage>65</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">9000892</pub-id><pub-id pub-id-type="doi">10.1037//0033-2909.121.1.65</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tannock</surname><given-names>R</given-names></name></person-group><article-title>Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research</article-title><source>J Child Psychol Psychiatry</source><year>1998</year><volume>39</volume><fpage>65</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">9534087</pub-id><pub-id pub-id-type="doi">10.1017/S0021963097001777</pub-id></citation></ref><ref id="B23"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>VI</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Bloomingdale LM, Sergeant JA</surname></name></person-group><article-title>Cognitive deficits in children with attention-deficit disorder with hyperactivity</article-title><source>In Attention deficit disorder: criteria, cognition, intervention</source><year>1988</year><publisher-name>London: Pergamon</publisher-name><fpage>65</fpage><lpage>82</lpage></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eisenberg</surname><given-names>J</given-names></name><name><surname>Mei-Tal</surname><given-names>G</given-names></name><name><surname>Steinberg</surname><given-names>A</given-names></name><name><surname>Tartakovsky</surname><given-names>E</given-names></name><name><surname>Zohar</surname><given-names>A</given-names></name><name><surname>Gritsenko</surname><given-names>I</given-names></name><name><surname>Nemanov</surname><given-names>L</given-names></name><name><surname>Ebstein</surname><given-names>RP</given-names></name></person-group><article-title>Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype</article-title><source>Am J Med Genet</source><year>1999</year><volume>88</volume><fpage>497</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">10490706</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinshilboum</surname><given-names>RM</given-names></name><name><surname>Otterness</surname><given-names>DM</given-names></name><name><surname>Szumlanski</surname><given-names>CL</given-names></name></person-group><article-title>Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase</article-title><source>Annu Rev Pharmacol Toxicol</source><year>1999</year><volume>39</volume><fpage>19</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">10331075</pub-id><pub-id pub-id-type="doi">10.1146/annurev.pharmtox.39.1.19</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lachman</surname><given-names>HM</given-names></name><name><surname>Papolos</surname><given-names>DF</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>YM</given-names></name><name><surname>Szumlanski</surname><given-names>CL</given-names></name><name><surname>Weinshilboum</surname><given-names>RM</given-names></name></person-group><article-title>Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders</article-title><source>Pharmacogenetics</source><year>1996</year><volume>6</volume><fpage>243</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">8807664</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giros</surname><given-names>B</given-names></name><name><surname>Jaber</surname><given-names>M</given-names></name><name><surname>Jones</surname><given-names>SR</given-names></name><name><surname>Wightman</surname><given-names>RM</given-names></name><name><surname>Caron</surname><given-names>MG</given-names></name></person-group><article-title>Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter</article-title><source>Nature</source><year>1996</year><volume>379</volume><fpage>606</fpage><lpage>612</lpage><pub-id pub-id-type="pmid">8628395</pub-id><pub-id pub-id-type="doi">10.1038/379606a0</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sesack</surname><given-names>SR</given-names></name><name><surname>Hawrylak</surname><given-names>VA</given-names></name><name><surname>Guido</surname><given-names>MA</given-names></name><name><surname>Levey</surname><given-names>AI</given-names></name></person-group><article-title>Cellular and subcellular localization of the dopamine transporter in rat cortex</article-title><source>Adv Pharmacol</source><year>1998</year><volume>42</volume><fpage>171</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">9327871</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DA</given-names></name><name><surname>Melchitzky</surname><given-names>DS</given-names></name><name><surname>Sesack</surname><given-names>SR</given-names></name><name><surname>Whitehead</surname><given-names>RE</given-names></name><name><surname>Auh</surname><given-names>S</given-names></name><name><surname>Sampson</surname><given-names>A</given-names></name></person-group><article-title>Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization</article-title><source>J Comp Neurol</source><year>2001</year><volume>432</volume><fpage>119</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">11241381</pub-id><pub-id pub-id-type="doi">10.1002/cne.1092</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dougherty</surname><given-names>DD</given-names></name><name><surname>Bonab</surname><given-names>AA</given-names></name><name><surname>Spencer</surname><given-names>TJ</given-names></name><name><surname>Rauch</surname><given-names>SL</given-names></name><name><surname>Madras</surname><given-names>BK</given-names></name><name><surname>Fischman</surname><given-names>AJ</given-names></name></person-group><article-title>Dopamine transporter density in patients with attention deficit hyperactivity disorder</article-title><source>Lancet</source><year>1999</year><volume>354</volume><fpage>2132</fpage><lpage>2133</lpage><pub-id pub-id-type="pmid">10609822</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(99)04030-1</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moron</surname><given-names>JA</given-names></name><name><surname>Brockington</surname><given-names>A</given-names></name><name><surname>Wise</surname><given-names>RA</given-names></name><name><surname>Rocha</surname><given-names>BA</given-names></name><name><surname>Hope</surname><given-names>BT</given-names></name></person-group><article-title>Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines</article-title><source>J Neurosci</source><year>2002</year><volume>22</volume><fpage>389</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">11784783</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wayment</surname><given-names>HK</given-names></name><name><surname>Schenk</surname><given-names>JO</given-names></name><name><surname>Sorg</surname><given-names>BA</given-names></name></person-group><article-title>Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition</article-title><source>J Neurosci</source><year>2001</year><volume>21</volume><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">11150317</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karoum</surname><given-names>F</given-names></name><name><surname>Chrapusta</surname><given-names>SJ</given-names></name><name><surname>Egan</surname><given-names>MF</given-names></name></person-group><article-title>3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model</article-title><source>J Neurochem</source><year>1994</year><volume>63</volume><fpage>972</fpage><lpage>979</lpage><pub-id pub-id-type="pmid">7914228</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elsworth</surname><given-names>JD</given-names></name><name><surname>Leahy</surname><given-names>DJ</given-names></name><name><surname>Roth</surname><given-names>RH</given-names></name><name><surname>Redmond</surname><given-names>DE</given-names><suffix>Jr</suffix></name></person-group><article-title>Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primates</article-title><source>J Neural Transm</source><year>1987</year><volume>68</volume><fpage>51</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">3806086</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gogos</surname><given-names>JA</given-names></name><name><surname>Morgan</surname><given-names>M</given-names></name><name><surname>Luine</surname><given-names>V</given-names></name><name><surname>Santha</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name><name><surname>Pfaff</surname><given-names>D</given-names></name><name><surname>Karayiorgou</surname><given-names>M</given-names></name></person-group><article-title>Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior</article-title><source>Proc Natl Acad Sci U S A</source><year>1998</year><volume>95</volume><fpage>9991</fpage><lpage>9996</lpage><pub-id pub-id-type="pmid">9707588</pub-id><pub-id pub-id-type="doi">10.1073/pnas.95.17.9991</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>AK</given-names></name><name><surname>Kestler</surname><given-names>LJ</given-names></name><name><surname>Mazzanti</surname><given-names>C</given-names></name><name><surname>Bates</surname><given-names>JA</given-names></name><name><surname>Goldberg</surname><given-names>T</given-names></name><name><surname>Goldman</surname><given-names>D</given-names></name></person-group><article-title>A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition</article-title><source>Am J Psychiatry</source><year>2002</year><volume>159</volume><fpage>652</fpage><lpage>654</lpage><pub-id pub-id-type="pmid">11925305</pub-id><pub-id pub-id-type="doi">10.1176/appi.ajp.159.4.652</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattay</surname><given-names>VS</given-names></name><name><surname>Goldberg</surname><given-names>TE</given-names></name><name><surname>Fera</surname><given-names>F</given-names></name><name><surname>Hariri</surname><given-names>AR</given-names></name><name><surname>Tessitore</surname><given-names>A</given-names></name><name><surname>Egan</surname><given-names>MF</given-names></name><name><surname>Kolachana</surname><given-names>B</given-names></name><name><surname>Callicott</surname><given-names>JH</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name></person-group><article-title>Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine</article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><fpage>6186</fpage><lpage>6191</lpage><pub-id pub-id-type="pmid">12716966</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0931309100</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinberger</surname><given-names>DR</given-names></name><name><surname>Berman</surname><given-names>KF</given-names></name></person-group><article-title>Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia</article-title><source>Schizophr Bull</source><year>1988</year><volume>14</volume><fpage>157</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">3059465</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>MF</given-names></name><name><surname>Goldberg</surname><given-names>TE</given-names></name><name><surname>Kolachana</surname><given-names>BS</given-names></name><name><surname>Callicott</surname><given-names>JH</given-names></name><name><surname>Mazzanti</surname><given-names>CM</given-names></name><name><surname>Straub</surname><given-names>RE</given-names></name><name><surname>Goldman</surname><given-names>D</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name></person-group><article-title>Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia</article-title><source>Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><fpage>6917</fpage><lpage>6922</lpage><pub-id pub-id-type="pmid">11381111</pub-id><pub-id pub-id-type="doi">10.1073/pnas.111134598</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joober</surname><given-names>R</given-names></name><name><surname>Gauthier</surname><given-names>J</given-names></name><name><surname>Lal</surname><given-names>S</given-names></name><name><surname>Bloom</surname><given-names>D</given-names></name><name><surname>Lalonde</surname><given-names>P</given-names></name><name><surname>Rouleau</surname><given-names>G</given-names></name><name><surname>Benkelfat</surname><given-names>C</given-names></name><name><surname>Labelle</surname><given-names>A</given-names></name></person-group><article-title>Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test</article-title><source>Arch Gen Psychiatry</source><year>2002</year><volume>59</volume><fpage>662</fpage><lpage>663</lpage><pub-id pub-id-type="pmid">12090821</pub-id><pub-id pub-id-type="doi">10.1001/archpsyc.59.7.662</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bilder</surname><given-names>RM</given-names></name><name><surname>Volavka</surname><given-names>J</given-names></name><name><surname>Czobor</surname><given-names>P</given-names></name><name><surname>Malhotra</surname><given-names>AK</given-names></name><name><surname>Kennedy</surname><given-names>JL</given-names></name><name><surname>Ni</surname><given-names>X</given-names></name><name><surname>Goldman</surname><given-names>RS</given-names></name><name><surname>Hoptman</surname><given-names>MJ</given-names></name><name><surname>Sheitman</surname><given-names>B</given-names></name><name><surname>Lindenmayer</surname><given-names>JP</given-names></name><name><surname>Citrome</surname><given-names>L</given-names></name><name><surname>McEvoy</surname><given-names>JP</given-names></name><name><surname>Kunz</surname><given-names>M</given-names></name><name><surname>Chakos</surname><given-names>M</given-names></name><name><surname>Cooper</surname><given-names>TB</given-names></name><name><surname>Lieberman</surname><given-names>JA</given-names></name></person-group><article-title>Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia</article-title><source>Biol Psychiatry</source><year>2002</year><volume>52</volume><fpage>701</fpage><lpage>707</lpage><pub-id pub-id-type="pmid">12372660</pub-id><pub-id pub-id-type="doi">10.1016/S0006-3223(02)01416-6</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Payton</surname><given-names>A</given-names></name><name><surname>Holmes</surname><given-names>J</given-names></name><name><surname>Barrett</surname><given-names>JH</given-names></name><name><surname>Hever</surname><given-names>T</given-names></name><name><surname>Fitzpatrick</surname><given-names>H</given-names></name><name><surname>Trumper</surname><given-names>AL</given-names></name><name><surname>Harrington</surname><given-names>R</given-names></name><name><surname>McGuffin</surname><given-names>P</given-names></name><name><surname>O'Donovan</surname><given-names>M</given-names></name><name><surname>Owen</surname><given-names>M</given-names></name><name><surname>Ollier</surname><given-names>W</given-names></name><name><surname>Worthington</surname><given-names>J</given-names></name><name><surname>Thapar</surname><given-names>A</given-names></name></person-group><article-title>Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study</article-title><source>Am J Med Genet</source><year>2001</year><volume>105</volume><fpage>464</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">11449400</pub-id><pub-id pub-id-type="doi">10.1002/ajmg.1407</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tahir</surname><given-names>E</given-names></name><name><surname>Yazgan</surname><given-names>Y</given-names></name><name><surname>Cirakoglu</surname><given-names>B</given-names></name><name><surname>Ozbay</surname><given-names>F</given-names></name><name><surname>Waldman</surname><given-names>I</given-names></name><name><surname>Asherson</surname><given-names>PJ</given-names></name></person-group><article-title>Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children</article-title><source>Mol Psychiatry</source><year>2000</year><volume>5</volume><fpage>396</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">10889550</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4000744</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirley</surname><given-names>A</given-names></name><name><surname>Hawi</surname><given-names>Z</given-names></name><name><surname>Daly</surname><given-names>G</given-names></name><name><surname>McCarron</surname><given-names>M</given-names></name><name><surname>Mullins</surname><given-names>C</given-names></name><name><surname>Millar</surname><given-names>N</given-names></name><name><surname>Waldman</surname><given-names>I</given-names></name><name><surname>Fitzgerald</surname><given-names>M</given-names></name><name><surname>Gill</surname><given-names>M</given-names></name></person-group><article-title>Dopaminergic system genes in ADHD: toward a biological hypothesis</article-title><source>Neuropsychopharmacology</source><year>2002</year><volume>27</volume><fpage>607</fpage><lpage>619</lpage><pub-id pub-id-type="pmid">12377397</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinberger</surname><given-names>DR</given-names></name></person-group><article-title>A connectionist approach to the prefrontal cortex</article-title><source>J Neuropsychiatry Clin Neurosci</source><year>1993</year><volume>5</volume><fpage>241</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">8369632</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elia</surname><given-names>J</given-names></name><name><surname>Gulotta</surname><given-names>C</given-names></name><name><surname>Rose</surname><given-names>SR</given-names></name><name><surname>Marin</surname><given-names>G</given-names></name><name><surname>Rapoport</surname><given-names>JL</given-names></name></person-group><article-title>Thyroid function and attention-deficit hyperactivity disorder</article-title><source>J Am Acad Child Adolesc Psychiatry</source><year>1994</year><volume>33</volume><fpage>169</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">8150787</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>DA</given-names></name><name><surname>Berg</surname><given-names>EAA</given-names></name></person-group><article-title>A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigel-type card-sorting problem</article-title><source>Journal of Experimental Psychology</source><year>1948</year><volume>38</volume><fpage>404</fpage><lpage>411</lpage></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shallice</surname><given-names>T</given-names></name></person-group><article-title>Specific impairments of planning</article-title><source>Philos Trans R Soc Lond B Biol Sci</source><year>1982</year><volume>298</volume><fpage>199</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">6125971</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Petrides</surname><given-names>M</given-names></name><name><surname>Milner</surname><given-names>B</given-names></name></person-group><article-title>Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man</article-title><source>Neuropsychologia</source><year>1982</year><volume>20</volume><fpage>249</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">7121793</pub-id><pub-id pub-id-type="doi">10.1016/0028-3932(82)90100-2</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lahey</surname><given-names>BB</given-names></name><name><surname>Applegate</surname><given-names>B</given-names></name><name><surname>McBurnett</surname><given-names>K</given-names></name><name><surname>Biederman</surname><given-names>J</given-names></name><name><surname>Greenhill</surname><given-names>L</given-names></name><name><surname>Hynd</surname><given-names>GW</given-names></name><name><surname>Barkley</surname><given-names>RA</given-names></name><name><surname>Newcorn</surname><given-names>J</given-names></name><name><surname>Jensen</surname><given-names>P</given-names></name><name><surname>Richters</surname><given-names>J</given-names></name></person-group><article-title>DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents</article-title><source>Am J Psychiatry</source><year>1994</year><volume>151</volume><fpage>1673</fpage><lpage>1685</lpage><pub-id pub-id-type="pmid">7943460</pub-id></citation></ref><ref id="B51"><citation citation-type="book"><person-group person-group-type="author"><collab>National Institute of Mental Health</collab></person-group><source>NIMH DISC-IV</source><year>1998</year><publisher-name>Joy and William Ruane Center to Identify and Treat Mood Disorders: Columbia University</publisher-name></citation></ref><ref id="B52"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Achenbach</surname><given-names>TM</given-names></name></person-group><source>The child behavior checklist/4&#x02013;18 and 1991 profile</source><year>1991</year><publisher-name>Burlington, Vermont, University of Vermont</publisher-name></citation></ref><ref id="B53"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Conners</surname><given-names>CK</given-names></name></person-group><source>Conners' Global Index-Parents. 2003</source><year>1997</year><publisher-name>North Noranda, NY, Multihealth Systems Inc</publisher-name></citation></ref><ref id="B54"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Conners</surname><given-names>CK</given-names></name></person-group><source>Conners' Global Index-Teacher. 2003</source><year>1997</year><publisher-name>North Noranda, NY, Multihealth Systems Inc</publisher-name></citation></ref><ref id="B55"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Wechsler</surname><given-names>D</given-names></name></person-group><source>Wechsler Intelligence Scale for Children-Third Edition: Manual</source><year>1991</year><publisher-name>San Antonio, TX: Psychological Corporation</publisher-name></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krikorian</surname><given-names>R</given-names></name><name><surname>Bartok</surname><given-names>J</given-names></name><name><surname>Gay</surname><given-names>N</given-names></name></person-group><article-title>Tower of London procedure: a standard method and developmental data</article-title><source>J Clin Exp Neuropsychol</source><year>1994</year><volume>16</volume><fpage>840</fpage><lpage>850</lpage><pub-id pub-id-type="pmid">7890819</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shue</surname><given-names>KL</given-names></name><name><surname>Douglas</surname><given-names>VI</given-names></name></person-group><article-title>Attention deficit hyperactivity disorder and the frontal lobe syndrome</article-title><source>Brain Cogn</source><year>1992</year><volume>20</volume><fpage>104</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">1389116</pub-id><pub-id pub-id-type="doi">10.1016/0278-2626(92)90064-S</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Cardon</surname><given-names>LR</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name></person-group><article-title>A general test of association for quantitative traits in nuclear families</article-title><source>Am J Hum Genet</source><year>2000</year><volume>66</volume><fpage>279</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">10631157</pub-id><pub-id pub-id-type="doi">10.1086/302698</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Glatt</surname><given-names>S</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name></person-group><article-title>Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism</article-title><source>Am J Med Genet</source><year>2003</year><volume>118B</volume><fpage>103</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1002/ajmg.b.10064</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barr</surname><given-names>CL</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Kroft</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Wigg</surname><given-names>K</given-names></name><name><surname>Zai</surname><given-names>G</given-names></name><name><surname>Tannock</surname><given-names>R</given-names></name><name><surname>Schachar</surname><given-names>R</given-names></name><name><surname>Malone</surname><given-names>M</given-names></name><name><surname>Roberts</surname><given-names>W</given-names></name><name><surname>Nothen</surname><given-names>MM</given-names></name><name><surname>Grunhage</surname><given-names>F</given-names></name><name><surname>Vandenbergh</surname><given-names>DJ</given-names></name><name><surname>Uhl</surname><given-names>G</given-names></name><name><surname>Sunohara</surname><given-names>G</given-names></name><name><surname>King</surname><given-names>N</given-names></name><name><surname>Kennedy</surname><given-names>JL</given-names></name></person-group><article-title>Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder</article-title><source>Biol Psychiatry</source><year>2001</year><volume>49</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">11239904</pub-id><pub-id pub-id-type="doi">10.1016/S0006-3223(00)01053-2</pub-id></citation></ref><ref id="B61"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Biederman</surname><given-names>J</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Davis K, Charney D, Coyle JT, Nemeroff C</surname></name></person-group><article-title>Pathophysiology of attention-deficit hyperactivity disorder</article-title><source>In ACNP's fifth generation of progress-version 2</source><year>2002</year><publisher-name>New York: Lipponcott, Williams, Wilkens</publisher-name></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>S</given-names></name><name><surname>Langley</surname><given-names>K</given-names></name><name><surname>Van den Bree</surname><given-names>M</given-names></name><name><surname>Street</surname><given-names>E</given-names></name><name><surname>Turic</surname><given-names>D</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name><name><surname>O'Donovan</surname><given-names>MC</given-names></name><name><surname>Thapar</surname><given-names>A</given-names></name></person-group><article-title>No evidence of association between Catechol-O-Methyltransferase (COMT) Val158Met genotype and performance on neuropsychological tasks in children with ADHD: a case-control study</article-title><source>BMC Psychiatry</source><year>2004</year><volume>4</volume><fpage>15</fpage><pub-id pub-id-type="pmid">15182372</pub-id><pub-id pub-id-type="doi">10.1186/1471-244X-4-15</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Demarest</surname><given-names>KT</given-names></name><name><surname>Riegle</surname><given-names>GD</given-names></name><name><surname>Moore</surname><given-names>KE</given-names></name></person-group><article-title>Characteristics of dopaminergic neurons in the aged male rat</article-title><source>Neuroendocrinology</source><year>1980</year><volume>31</volume><fpage>222</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">6774278</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Estes</surname><given-names>KS</given-names></name><name><surname>Simpkins</surname><given-names>JW</given-names></name></person-group><article-title>Age-related alterations in catecholamine concentrations in discrete preoptic area and hypothalamic regions in the male rat</article-title><source>Brain Res</source><year>1980</year><volume>194</volume><fpage>556</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">7388632</pub-id><pub-id pub-id-type="doi">10.1016/0006-8993(80)91241-X</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Chang</surname><given-names>CK</given-names></name><name><surname>Liu</surname><given-names>IM</given-names></name><name><surname>Chi</surname><given-names>TC</given-names></name><name><surname>Yu</surname><given-names>HJ</given-names></name><name><surname>Cheng</surname><given-names>JT</given-names></name></person-group><article-title>Changes in endogenous monoamines in aged rats</article-title><source>Clin Exp Pharmacol Physiol</source><year>2001</year><volume>28</volume><fpage>285</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">11251641</pub-id><pub-id pub-id-type="doi">10.1046/j.1440-1681.2001.03439.x</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carlsson</surname><given-names>A</given-names></name><name><surname>Winblad</surname><given-names>B</given-names></name></person-group><article-title>Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia</article-title><source>J Neural Transm</source><year>1976</year><volume>38</volume><fpage>271</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">956813</pub-id></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riederer</surname><given-names>P</given-names></name><name><surname>Wuketich</surname><given-names>S</given-names></name></person-group><article-title>Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis</article-title><source>J Neural Transm</source><year>1976</year><volume>38</volume><fpage>277</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">956814</pub-id></citation></ref><ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stramentinoli</surname><given-names>G</given-names></name><name><surname>Gualano</surname><given-names>M</given-names></name><name><surname>Algeri</surname><given-names>S</given-names></name><name><surname>de Gaetano</surname><given-names>G</given-names></name><name><surname>Rossi</surname><given-names>EC</given-names></name></person-group><article-title>Catechol-o-methyl transferase (COMT) in human and rat platelets</article-title><source>Thromb Haemost</source><year>1978</year><volume>39</volume><fpage>238</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">580500</pub-id></citation></ref><ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Venero</surname><given-names>JL</given-names></name><name><surname>Machado</surname><given-names>A</given-names></name><name><surname>Cano</surname><given-names>J</given-names></name></person-group><article-title>Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats</article-title><source>J Neurochem</source><year>1991</year><volume>56</volume><fpage>1940</fpage><lpage>1948</lpage><pub-id pub-id-type="pmid">1709201</pub-id></citation></ref><ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galva</surname><given-names>MD</given-names></name><name><surname>Bondiolotti</surname><given-names>GP</given-names></name><name><surname>Olasmaa</surname><given-names>M</given-names></name><name><surname>Picotti</surname><given-names>GB</given-names></name></person-group><article-title>Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex</article-title><source>J Neural Transm Gen Sect</source><year>1995</year><volume>101</volume><fpage>83</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">8695059</pub-id></citation></ref><ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>SZ</given-names></name><name><surname>Ozawa</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Takashima</surname><given-names>S</given-names></name></person-group><article-title>Developmental and age-related changes of dopamine transporter, and dopamine D1 and D2 receptors in human basal ganglia</article-title><source>Brain Res</source><year>1999</year><volume>843</volume><fpage>136</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">10528120</pub-id><pub-id pub-id-type="doi">10.1016/S0006-8993(99)01933-2</pub-id></citation></ref><ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>M</given-names></name><name><surname>Daly</surname><given-names>G</given-names></name><name><surname>Heron</surname><given-names>S</given-names></name><name><surname>Hawi</surname><given-names>Z</given-names></name><name><surname>Fitzgerald</surname><given-names>M</given-names></name></person-group><article-title>Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism</article-title><source>Mol Psychiatry</source><year>1997</year><volume>2</volume><fpage>311</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">9246671</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4000290</pub-id></citation></ref><ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roman</surname><given-names>T</given-names></name><name><surname>Schmitz</surname><given-names>M</given-names></name><name><surname>Polanczyk</surname><given-names>G</given-names></name><name><surname>Eizirik</surname><given-names>M</given-names></name><name><surname>Rohde</surname><given-names>LA</given-names></name><name><surname>Hutz</surname><given-names>MH</given-names></name></person-group><article-title>Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene</article-title><source>Am J Med Genet</source><year>2001</year><volume>105</volume><fpage>471</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">11449401</pub-id><pub-id pub-id-type="doi">10.1002/ajmg.1408</pub-id></citation></ref><ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rowe</surname><given-names>DC</given-names></name><name><surname>Stever</surname><given-names>C</given-names></name><name><surname>Chase</surname><given-names>D</given-names></name><name><surname>Sherman</surname><given-names>S</given-names></name><name><surname>Abramowitz</surname><given-names>A</given-names></name><name><surname>Waldman</surname><given-names>ID</given-names></name></person-group><article-title>Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms</article-title><source>Mol Psychiatry</source><year>2001</year><volume>6</volume><fpage>429</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">11443528</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4000874</pub-id></citation></ref><ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>P</given-names></name><name><surname>Roberts</surname><given-names>AC</given-names></name><name><surname>Dias</surname><given-names>R</given-names></name><name><surname>Everitt</surname><given-names>BJ</given-names></name><name><surname>Robbins</surname><given-names>TW</given-names></name></person-group><article-title>Perseveration and strategy in a novel spatial self-ordered sequencing task for nonhuman primates: effects of excitotoxic lesions and dopamine depletions of the prefrontal cortex</article-title><source>J Cogn Neurosci</source><year>1998</year><volume>10</volume><fpage>332</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">9869708</pub-id><pub-id pub-id-type="doi">10.1162/089892998562771</pub-id></citation></ref></ref-list></back></article> 